Structures by: Mahapatra S.
Total: 30
C58H86O16S2Si2
C58H86O16S2Si2
Chemical Science (2020)
a=17.8150(12)Å b=18.8153(13)Å c=19.2663(13)Å
α=90° β=90° γ=90°
C23H31N
C23H31N
Organic letters (2016) 18, 24 6392-6395
a=7.1278(5)Å b=11.0317(7)Å c=24.0691(17)Å
α=90° β=90° γ=90°
6-Chloro-3-(2,2-dibromoacetyl)-2<i>H</i>-chromen-2-one
C11H5Br2ClO3
IUCrData (2017) 2, 3 x170356
a=7.9086(16)Å b=6.7115(10)Å c=22.640(3)Å
α=90° β=96.744(16)° γ=90°
30julb
C24H23O4
Chemical communications (Cambridge, England) (2015) 51, 14 2871
a=8.814(2)Å b=9.199(3)Å c=24.640(7)Å
α=90.00° β=90.00° γ=90.00°
Diethyl oxalate
C6H10O4
Acta Crystallographica Section B (2011) 67, 6 525-534
a=11.581(4)Å b=4.2812(15)Å c=15.282(5)Å
α=90° β=104.938(6)° γ=90°
Diethyl oxalate
C6H10O4
Acta Crystallographica Section B (2011) 67, 6 525-534
a=11.734(4)Å b=4.3096(15)Å c=15.276(5)Å
α=90° β=105.525(6)° γ=90°
Di-tert-butyl oxalate
C10H18O4
Acta Crystallographica Section B (2011) 67, 6 525-534
a=11.197(2)Å b=10.778(2)Å c=11.454(2)Å
α=90° β=119.23(3)° γ=90°
Di-tert-butyl oxalate
C10H18O4
Acta Crystallographica Section B (2011) 67, 6 525-534
a=11.183(2)Å b=10.752(2)Å c=11.405(2)Å
α=90° β=118.95(3)° γ=90°
Di-tert-butyl oxalate
C10H18O4
Acta Crystallographica Section B (2011) 67, 6 525-534
a=11.163(2)Å b=10.720(2)Å c=11.359(2)Å
α=90° β=118.75(3)° γ=90°
Di-tert-butyl oxalate
C10H18O4
Acta Crystallographica Section B (2011) 67, 6 525-534
a=11.138(2)Å b=10.686(2)Å c=11.324(2)Å
α=90° β=118.61(3)° γ=90°
Di-tert-butyl oxalate
C10H18O4
Acta Crystallographica Section B (2011) 67, 6 525-534
a=11.120(2)Å b=10.650(2)Å c=11.277(2)Å
α=90° β=118.35(3)° γ=90°
Di-tert-butyl oxalate
C10H18O4
Acta Crystallographica Section B (2011) 67, 6 525-534
a=11.100(2)Å b=10.635(2)Å c=11.243(2)Å
α=90° β=118.22(3)° γ=90°
Methyl ethyl oxalate
C5H8O4
Acta Crystallographica Section B (2011) 67, 6 525-534
a=16.317(8)Å b=4.461(2)Å c=9.254(4)Å
α=90° β=95.045(7)° γ=90°
Methy lethyl oxalate
C5H8O4
Acta Crystallographica Section B (2011) 67, 6 525-534
a=16.321(8)Å b=4.425(2)Å c=9.127(4)Å
α=90° β=95.092(8)° γ=90°
Dimethyl oxalate
C4H6O4
Acta Crystallographica Section B (2011) 67, 6 525-534
a=3.9101(19)Å b=11.907(5)Å c=6.221(3)Å
α=90° β=103.10(5)° γ=90°
Dimethyl oxalate
C4H6O4
Acta Crystallographica Section B (2011) 67, 6 525-534
a=3.873(2)Å b=11.875(4)Å c=6.205(2)Å
α=90° β=103.37(4)° γ=90°
Dimethyl oxalate
C4H6O4
Acta Crystallographica Section B (2011) 67, 6 525-534
a=3.851(2)Å b=11.840(6)Å c=6.227(3)Å
α=90° β=104.31(5)° γ=90°
Dimethyl oxalate
C4H6O4
Acta Crystallographica Section B (2011) 67, 6 525-534
a=3.8083(15)Å b=11.742(4)Å c=6.1664(18)Å
α=90° β=104.06(3)° γ=90°
Diisopropyl oxalate
C8H14O4
Acta Crystallographica Section B (2011) 67, 6 525-534
a=4.3575(12)Å b=9.949(3)Å c=11.384(3)Å
α=90° β=92.483(5)° γ=90°
Diisopropyl oxalate
C8H14O4
Acta Crystallographica Section B (2011) 67, 6 525-534
a=4.2679(17)Å b=9.947(4)Å c=11.272(5)Å
α=90° β=92.444(7)° γ=90°
Di-n-butyl oxalate
C10H18O4
Acta Crystallographica Section B (2011) 67, 6 525-534
a=4.593(4)Å b=4.702(4)Å c=14.030(11)Å
α=95.896(12)° β=97.964(12)° γ=96.656(13)°
Di-n-butyl oxalate
C10H18O4
Acta Crystallographica Section B (2011) 67, 6 525-534
a=4.360(2)Å b=4.611(2)Å c=13.954(7)Å
α=81.486(11)° β=81.175(8)° γ=81.044(8)°
3-(bromoacetyl)-6-chloro-2H-chromen-2-one
C11H6BrClO3
Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 8 o615-6
a=12.5770(2)Å b=5.79770(10)Å c=14.8390(3)Å
α=90° β=94.679(2)° γ=90°
Garcinia lactone
C6H6O7
Acta Crystallographica Section E (2007) 63, 9 o3869-o3869
a=6.2657(10)Å b=8.6591(14)Å c=13.504(2)Å
α=90° β=90° γ=90°
Quinoxaline
C8H6N2
Acta Crystallographica Section E (2010) 66, 11 o2789
a=4.0212(13)Å b=7.187(2)Å c=23.095(7)Å
α=90° β=90° γ=90°
Bromhexine-PTSA salt
C14H21Br2N2,C7H7O3S
Acta Crystallographica Section E (2011) 67, 8 o2032
a=14.008(5)Å b=10.404(5)Å c=17.157(5)Å
α=90° β=110.148(5)° γ=90°
3-(bromoacetyl)-6-fluoro-2H-chromen-2-one
C11H6BrFO3
Acta Crystallographica Section E (2011) 67, 9 o2264
a=4.0590(5)Å b=11.7719(13)Å c=21.608(2)Å
α=90° β=94.318(10)° γ=90°
ANHYDROUS CIPROFLOXACIN
C17H18FN3O3
Crystal Growth & Design (2010) 10, 4 1866
a=8.0622(15)Å b=9.730(2)Å c=10.3214(19)Å
α=99.927(17)° β=104.541(17)° γ=98.073(17)°
Medazolam
C18H13ClFN3
Crystal Growth & Design (2010) 10, 4 1866
a=7.5588(3)Å b=13.6840(5)Å c=15.1242(8)Å
α=90° β=92.497(5)° γ=90°
Anhydrous Ofloxacin
C18H20FN3O4
Crystal Growth & Design (2010) 10, 4 1866
a=30.322(4)Å b=6.8607(8)Å c=16.9199(16)Å
α=90° β=105.271(11)° γ=90°